Why BioNTech And Moderna Shares Are Falling After Pfizer News

BioNTech SE - ADR BNTX and Moderna Inc MRNA shares are trading lower Tuesday morning in sympathy with Pfizer Inc. PFE after the company issued FY23 guidance below estimates. Also, the Biden Administration said it plans to end COVID-19 emergency declarations on May 11.

See Also: Biden Administration Plans To End COVID-19 Public Health Emergency In May

Pfizer's FY23 Outlook

Pfizer forecasts FY23 sales to fall to $67-$71 billion from $100 billion in 2022 versus the consensus of $74.13 billion.

The company expects adjusted EPS guidance of $3.25-$3.45, down from $6.58 in 2022 and the consensus of $4.44...Read More

According to data from Benzinga Pro:

  • BNTX shares are trading lower by 2.63% to $136.80
  • MRNA is lower by 2.69% to $176.00
Market News and Data brought to you by Benzinga APIs
Posted In: Newswhy it's moving
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!